查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1829623

2025年全球血糖監測系統市場報告

Blood Glucose Monitoring Systems Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，血糖監測系統市場成長強勁，2024年將達到164.8億美元，2025年將達176.6億美元，複合年成長率為7.2%。這段時期的成長歸因於全球糖尿病患者數量的增加、人們意識的增強導致監測系統的應用增加、糖尿病管理支持性政策的訂定、醫療機構可及性的改善以及血糖儀準確性的提高。

預計未來幾年血糖監測系統市場規模將強勁成長，2029年將達到232.9億美元，複合年成長率為7.2%。預測期內的成長可歸因於利用血糖數據制定治療方案、糖尿病盛行率上升、老年人口成長、發展中地區應用率提高、互聯互通增強以及數據管理。預測期內的主要趨勢包括與穿戴式裝置和智慧型裝置的整合、感測器技術的進步、個人化醫療、遠端醫療、遠端監控以及互聯互通和資料管理的增強。

血糖監測系統是醫療設備。它通常包含一個緊湊的攜帶式血糖儀和一個通過指尖滴血給藥的試紙。這些系統在糖尿病管理中發揮重要作用，可以幫助患者監測和調節血糖值。

血糖監測系統主要分為兩種：非侵入性和侵入性。非侵入性系統無需採血，包括持續血糖監測系統、指尖或其他部位的自我監測系統等。這些系統透過醫療保健提供者和零售商銷售，用於治療第2型糖尿病、第一型糖尿病和妊娠糖尿病等。

2025年春季，美國關稅上調及其引發的貿易摩擦對醫療設備產業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場准入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供血糖監測系統市場統計數據，包括全球市場規模、區域佔有率、血糖監測系統市場佔有率競爭對手、詳細的血糖監測系統細分市場、市場趨勢和商機，以及您在血糖監測系統行業取得成功所需的數據。本血糖監測系統市場研究報告對該行業的現狀和未來情況進行了詳細分析，為您提供所需的一切資訊的完整展望。

未來五年7.2%的預測成長率，較我們先前對該市場的預測略有下降0.6%。下降主要源自於美國與其他國家之間關稅的影響。美國可能會直接感受到這種影響，因為來自德國和馬來西亞等主要地區的生物感測器晶片和酶標試紙的供應鏈中斷，導致糖尿病管理成本上升，並可能出現監測用品短缺。由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響，這種影響也可能波及更廣泛的地區。

糖尿病盛行率的上升預計將在未來幾年推動血糖監測系統市場的擴張。糖尿病患者的增加歸因於久坐不動的生活方式、不良飲食、人口老化和遺傳傾向等因素。血糖監測系統對於追蹤和管理血糖值、支持疾病管理和預防併發症至關重要。例如，根據澳洲政府機構澳洲統計局 2023 年 12 月的報告，2022 年將有 5.3% 的澳洲人（約 130 萬人）被診斷出患有糖尿病，男性（5.8%）和女性（4.9%）的盛行率相似。糖尿病的盛行率穩定上升，在 75 歲及以上人口中達到 18.7%。 2 型糖尿病佔病例的 87.6%，是最常見的類型。出生於海外、生活在貧困地區和殘疾等因素導致糖尿病發生率上升。因此，糖尿病盛行率的不斷上升預計將推動血糖監測系統市場的成長。

血糖監測系統市場的主要企業正專注於混合閉合迴路系統和智慧型手機應用程式等先進技術，以實現即時數據存取和管理。混合閉合迴路系統可根據即時血糖測量自動注射胰島素，進而增強糖尿病患者的血糖控制。例如，美國製造商 DexCom Inc. 於 2024 年 2 月在多個歐洲國家推出了 Dexcom ONE+。該系統整合了先進的感測器技術和方便用戶使用的功能，包括防水感測器、用於持續血糖監測的發射器以及兼容智慧型手機的應用程式。 Dexcom ONE+ 讓使用者和最多 10 名其他使用者即時監測血糖值，從而實現共用監測。

2023年9月，雅培實驗室收購了專注於糖尿病管理技術的美國公司Bigfoot Biomedical，擴大了其糖尿病管理產品組合。這項策略措施增強了雅培在糖尿病患者血糖監測和胰島素管理解決方案方面的能力。

血糖監測系統市場涵蓋血糖儀、試紙、採血針和採血筆的銷售。該市場的價值指的是“出廠價”，即商品製造商或生產商銷售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接銷售給最終客戶的商品價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球血糖監測系統：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球血糖監測系統市場：成長率分析
  • 全球血糖監測系統市場表現：規模與成長，2019-2024
  • 全球血糖監測系統市場預測：規模與成長，2024-2029年，2034年
  • 全球血糖監測系統：總目標市場（TAM）

第6章 市場細分

  • 全球血糖監測系統市場類型、效能及預測（2019-2024、2024-2029、2034）
  • 非侵入性
  • 侵入性
  • 全球血糖監測系統市場（按設備類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 連續血糖監測系統
  • 自我監測血糖監測系統
  • 全球血糖監測系統市場：按測量地點、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 指尖
  • 替代站點
  • 全球血糖監測系統市場（依通路）：績效與預測，2019-2024 年、2024-2029 年、2034 年
  • 機構銷售
  • 零售
  • 全球血糖監測系統市場應用、效能及預測（2019-2024、2024-2029、2034）
  • 2型糖尿病
  • 1型糖尿病
  • 妊娠糖尿病
  • 全球血糖監測系統市場：按非侵入式、類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 光學感測器
  • 超音波感測器
  • 基於電阻的感測器
  • 電磁感測器
  • 基於淚液或唾液的感測器
  • 全球血糖監測系統市場：按侵入性、類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 持續血糖監測（CGM）系統
  • 自我監測血糖（SMBG）系統
  • 植入式血糖監測設備
  • Flash血糖監測系統

第7章 區域和國家分析

  • 全球血糖監測系統市場：依地區、績效及預測，2019-2024年、2024-2029年、2034年
  • 全球血糖監測系統市場：依國家、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 血糖監測系統市場：競爭格局
  • 血糖監測系統市場：公司簡介
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Novo Nordisk A/S Overview, Products and Services, Strategy and Financial Analysis
    • B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Terumo India Private Limited
  • Dexcom Inc.
  • SD Biosensor Co. Ltd.
  • Arkray Inc.
  • Abbott India Limited
  • Ypsomed Holding AG
  • LifeScan IP Holdings LLC
  • Ascensia Diabetes Care Holdings AG
  • TaiDoc Technology Corporation
  • Nemaura Medical Inc.
  • Bionime GmbH
  • Acon Laboratories Inc.
  • Nipro India Corporation Private Limited
  • Rossmax International Ltd
  • AgaMatrix Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年血糖監測系統市場：提供新機會的國家
  • 2029年血糖監測系統市場：細分市場帶來新機會
  • 2029年血糖監測系統市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r29633u

A blood glucose monitoring system is a medical device designed to measure and show the concentration of glucose in the blood. It typically includes a compact, portable meter and a test strip where a drop of blood from a fingertip is applied. This system plays a crucial role in diabetes management by enabling individuals to monitor and regulate their blood sugar levels.

There are two main types of blood glucose monitoring systems non-invasive and invasive. Non-invasive systems do not require drawing blood and include devices such as continuous glucose monitoring systems and self-monitoring blood glucose systems for fingertip and alternative site testing. These systems are sold through institutional and retail channels, serving applications in type 2 diabetes, type 1 diabetes, and gestational diabetes.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The blood glucose monitoring systems market research report is one of a series of new reports from The Business Research Company that provides blood glucose monitoring systems market statistics, including the blood glucose monitoring systems industry's global market size, regional shares, competitors with a blood glucose monitoring systems market share, detailed blood glucose monitoring systems market segments, market trends and opportunities, and any further data you may need to thrive in the blood glucose monitoring systems industry. This blood glucose monitoring systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The blood glucose monitoring systems market size has grown strongly in recent years. It will grow from $16.48 billion in 2024 to $17.66 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to increased cases of diabetes globally, greater awareness leading to increased adoption of monitoring systems, supportive policies for diabetes management, improved access to healthcare facilities, and improved accuracy of glucose meters.

The blood glucose monitoring systems market size is expected to see strong growth in the next few years. It will grow to $23.29 billion in 2029 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to tailored treatment plans using glucose data, increasing prevalence of diabetes, rising geriatric population, increasing adoption in developing regions, enhanced connectivity, and data management. Major trends in the forecast period include integration with wearable and smart devices, advancements in sensor technology, personalized medicine, telehealth, and remote monitoring, and enhanced connectivity and data management.

The forecast of 7.2% growth over the next five years reflects a modest reduction of 0.6% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for biosensor chips and enzyme-coated test strips, sourced from key regions such as Germany and Malaysia, which could lead to increased costs for diabetes management and potential shortages of monitoring supplies.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing prevalence of diabetes is expected to drive the expansion of the blood glucose monitoring systems market in the coming years. The increase in diabetes cases can be attributed to factors such as sedentary lifestyles, poor dietary habits, aging populations, and genetic predisposition. Blood glucose monitoring systems are essential for tracking and managing blood sugar levels, supporting disease control, and preventing complications. For example, in December 2023, the Australian Bureau of Statistics, a government agency based in Australia, reported that in 2022, 5.3% of Australians, or around 1.3 million people, were diagnosed with diabetes, with similar rates between males (5.8%) and females (4.9%). The prevalence of diabetes has been steadily rising, particularly with age, reaching 18.7% among individuals aged 75 and older. Type 2 diabetes, which accounts for 87.6% of cases, is the most common form. Factors such as being born overseas, living in disadvantaged areas, and having a disability are linked to higher diabetes rates. As a result, the increasing prevalence of diabetes is expected to drive the growth of the blood glucose monitoring systems market.

Leading companies in the glucose monitoring systems market are focused on advancing technologies such as hybrid closed-loop systems and smartphone applications for real-time data access and management. Hybrid closed-loop systems automate insulin delivery based on real-time glucose readings, enhancing blood sugar control for individuals with diabetes. For instance, DexCom Inc., a US-based manufacturer, introduced Dexcom ONE+ in multiple European countries in February 2024. This system integrates advanced sensor technology and user-friendly features, including a water-resistant sensor, a transmitter for continuous glucose monitoring, and a smartphone-compatible app. Dexcom ONE+ allows real-time monitoring of blood glucose levels by users and up to ten additional individuals, facilitating shared monitoring.

In September 2023, Abbott Laboratories expanded its diabetes management portfolio by acquiring Bigfoot Biomedical Inc., a US-based company specializing in diabetes management technology. This strategic move strengthens Abbott's capabilities in glucose monitoring and insulin management solutions for diabetic patients.

Major companies operating in the blood glucose monitoring systems market are F. Hoffmann-La Roche Ltd., Sanofi S.A., Medtronic plc, Novo Nordisk A/S, B. Braun Melsungen AG, Terumo India Private Limited, Dexcom Inc., SD Biosensor Co. Ltd., Arkray Inc., Abbott India Limited, Ypsomed Holding AG, LifeScan IP Holdings LLC, Ascensia Diabetes Care Holdings AG, TaiDoc Technology Corporation, Nemaura Medical Inc., Bionime GmbH, Acon Laboratories Inc., Nipro India Corporation Private Limited., Rossmax International Ltd, AgaMatrix Inc., A. Menarini Diagnostics S.r.l., Medisana GmbH, Intuity Medical Inc.

North America was the largest region in the blood glucose monitoring systems market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the blood glucose monitoring systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the blood glucose monitoring systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The blood glucose monitoring systems market consists of sales of blood glucose meters, test strips, lancets, and lancing devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Blood Glucose Monitoring Systems Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on blood glucose monitoring systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for blood glucose monitoring systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The blood glucose monitoring systems market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Non-Invasive; Invasive
  • 2) By Device Type: Continuous Glucose Monitoring Systems; Self-Monitoring Blood Glucose Systems
  • 3) By Testing Site: Fingertip Testing; Alternate Site Testing
  • 4) By Distribution Channel: Institutional Sales; Retail Sales
  • 5) By Application: Type 2 Diabetes; Type 1 Diabetes; Gestational Diabetes
  • Subsegments:
  • 1) By Non-Invasive: Optical Sensors; Ultrasound-Based Sensors; Bioimpedance-Based Sensors; Electromagnetic Sensors; Tear Or Saliva-Based Sensors
  • 2) By Invasive: Continuous Glucose Monitoring (CGM) Systems; Self-Monitoring Blood Glucose (SMBG) Systems; Implantable Glucose Monitoring Devices; Flash Glucose Monitoring Systems
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Sanofi S.A.; Medtronic plc; Novo Nordisk A/S; B. Braun Melsungen AG; Terumo India Private Limited; Dexcom Inc.; SD Biosensor Co. Ltd.; Arkray Inc.; Abbott India Limited; Ypsomed Holding AG; LifeScan IP Holdings LLC; Ascensia Diabetes Care Holdings AG; TaiDoc Technology Corporation; Nemaura Medical Inc.; Bionime GmbH; Acon Laboratories Inc.; Nipro India Corporation Private Limited.; Rossmax International Ltd; AgaMatrix Inc.; A. Menarini Diagnostics S.r.l.; Medisana GmbH; Intuity Medical Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Blood Glucose Monitoring Systems Market Characteristics

3. Blood Glucose Monitoring Systems Market Trends And Strategies

4. Blood Glucose Monitoring Systems Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Blood Glucose Monitoring Systems Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Blood Glucose Monitoring Systems PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Blood Glucose Monitoring Systems Market Growth Rate Analysis
  • 5.4. Global Blood Glucose Monitoring Systems Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Blood Glucose Monitoring Systems Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Blood Glucose Monitoring Systems Total Addressable Market (TAM)

6. Blood Glucose Monitoring Systems Market Segmentation

  • 6.1. Global Blood Glucose Monitoring Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Non-Invasive
  • Invasive
  • 6.2. Global Blood Glucose Monitoring Systems Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Continuous Glucose Monitoring Systems
  • Self-Monitoring Blood Glucose Systems
  • 6.3. Global Blood Glucose Monitoring Systems Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Fingertip Testing
  • Alternate Site Testing
  • 6.4. Global Blood Glucose Monitoring Systems Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Institutional Sales
  • Retail Sales
  • 6.5. Global Blood Glucose Monitoring Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Type 2 Diabetes
  • Type 1 Diabetes
  • Gestational Diabetes
  • 6.6. Global Blood Glucose Monitoring Systems Market, Sub-Segmentation Of Non-Invasive, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Optical Sensors
  • Ultrasound-Based Sensors
  • Bioimpedance-Based Sensors
  • Electromagnetic Sensors
  • Tear Or Saliva-Based Sensors
  • 6.7. Global Blood Glucose Monitoring Systems Market, Sub-Segmentation Of Invasive, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Continuous Glucose Monitoring (CGM) Systems
  • Self-Monitoring Blood Glucose (SMBG) Systems
  • Implantable Glucose Monitoring Devices
  • Flash Glucose Monitoring Systems

7. Blood Glucose Monitoring Systems Market Regional And Country Analysis

  • 7.1. Global Blood Glucose Monitoring Systems Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Blood Glucose Monitoring Systems Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Blood Glucose Monitoring Systems Market

  • 8.1. Asia-Pacific Blood Glucose Monitoring Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Blood Glucose Monitoring Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Blood Glucose Monitoring Systems Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Blood Glucose Monitoring Systems Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Blood Glucose Monitoring Systems Market

  • 9.1. China Blood Glucose Monitoring Systems Market Overview
  • 9.2. China Blood Glucose Monitoring Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Blood Glucose Monitoring Systems Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Blood Glucose Monitoring Systems Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Blood Glucose Monitoring Systems Market

  • 10.1. India Blood Glucose Monitoring Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Blood Glucose Monitoring Systems Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Blood Glucose Monitoring Systems Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Blood Glucose Monitoring Systems Market

  • 11.1. Japan Blood Glucose Monitoring Systems Market Overview
  • 11.2. Japan Blood Glucose Monitoring Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Blood Glucose Monitoring Systems Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Blood Glucose Monitoring Systems Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Blood Glucose Monitoring Systems Market

  • 12.1. Australia Blood Glucose Monitoring Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Blood Glucose Monitoring Systems Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Blood Glucose Monitoring Systems Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Blood Glucose Monitoring Systems Market

  • 13.1. Indonesia Blood Glucose Monitoring Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Blood Glucose Monitoring Systems Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Blood Glucose Monitoring Systems Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Blood Glucose Monitoring Systems Market

  • 14.1. South Korea Blood Glucose Monitoring Systems Market Overview
  • 14.2. South Korea Blood Glucose Monitoring Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Blood Glucose Monitoring Systems Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Blood Glucose Monitoring Systems Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Blood Glucose Monitoring Systems Market

  • 15.1. Western Europe Blood Glucose Monitoring Systems Market Overview
  • 15.2. Western Europe Blood Glucose Monitoring Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Blood Glucose Monitoring Systems Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Blood Glucose Monitoring Systems Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Blood Glucose Monitoring Systems Market

  • 16.1. UK Blood Glucose Monitoring Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Blood Glucose Monitoring Systems Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Blood Glucose Monitoring Systems Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Blood Glucose Monitoring Systems Market

  • 17.1. Germany Blood Glucose Monitoring Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Blood Glucose Monitoring Systems Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Blood Glucose Monitoring Systems Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Blood Glucose Monitoring Systems Market

  • 18.1. France Blood Glucose Monitoring Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Blood Glucose Monitoring Systems Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Blood Glucose Monitoring Systems Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Blood Glucose Monitoring Systems Market

  • 19.1. Italy Blood Glucose Monitoring Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Blood Glucose Monitoring Systems Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Blood Glucose Monitoring Systems Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Blood Glucose Monitoring Systems Market

  • 20.1. Spain Blood Glucose Monitoring Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Blood Glucose Monitoring Systems Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Blood Glucose Monitoring Systems Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Blood Glucose Monitoring Systems Market

  • 21.1. Eastern Europe Blood Glucose Monitoring Systems Market Overview
  • 21.2. Eastern Europe Blood Glucose Monitoring Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Blood Glucose Monitoring Systems Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Blood Glucose Monitoring Systems Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Blood Glucose Monitoring Systems Market

  • 22.1. Russia Blood Glucose Monitoring Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Blood Glucose Monitoring Systems Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Blood Glucose Monitoring Systems Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Blood Glucose Monitoring Systems Market

  • 23.1. North America Blood Glucose Monitoring Systems Market Overview
  • 23.2. North America Blood Glucose Monitoring Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Blood Glucose Monitoring Systems Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Blood Glucose Monitoring Systems Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Blood Glucose Monitoring Systems Market

  • 24.1. USA Blood Glucose Monitoring Systems Market Overview
  • 24.2. USA Blood Glucose Monitoring Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Blood Glucose Monitoring Systems Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Blood Glucose Monitoring Systems Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Blood Glucose Monitoring Systems Market

  • 25.1. Canada Blood Glucose Monitoring Systems Market Overview
  • 25.2. Canada Blood Glucose Monitoring Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Blood Glucose Monitoring Systems Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Blood Glucose Monitoring Systems Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Blood Glucose Monitoring Systems Market

  • 26.1. South America Blood Glucose Monitoring Systems Market Overview
  • 26.2. South America Blood Glucose Monitoring Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Blood Glucose Monitoring Systems Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Blood Glucose Monitoring Systems Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Blood Glucose Monitoring Systems Market

  • 27.1. Brazil Blood Glucose Monitoring Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Blood Glucose Monitoring Systems Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Blood Glucose Monitoring Systems Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Blood Glucose Monitoring Systems Market

  • 28.1. Middle East Blood Glucose Monitoring Systems Market Overview
  • 28.2. Middle East Blood Glucose Monitoring Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Blood Glucose Monitoring Systems Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Blood Glucose Monitoring Systems Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Blood Glucose Monitoring Systems Market

  • 29.1. Africa Blood Glucose Monitoring Systems Market Overview
  • 29.2. Africa Blood Glucose Monitoring Systems Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Blood Glucose Monitoring Systems Market, Segmentation By Device Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Blood Glucose Monitoring Systems Market, Segmentation By Testing Site, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Blood Glucose Monitoring Systems Market Competitive Landscape And Company Profiles

  • 30.1. Blood Glucose Monitoring Systems Market Competitive Landscape
  • 30.2. Blood Glucose Monitoring Systems Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Novo Nordisk A/S Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis

31. Blood Glucose Monitoring Systems Market Other Major And Innovative Companies

  • 31.1. Terumo India Private Limited
  • 31.2. Dexcom Inc.
  • 31.3. SD Biosensor Co. Ltd.
  • 31.4. Arkray Inc.
  • 31.5. Abbott India Limited
  • 31.6. Ypsomed Holding AG
  • 31.7. LifeScan IP Holdings LLC
  • 31.8. Ascensia Diabetes Care Holdings AG
  • 31.9. TaiDoc Technology Corporation
  • 31.10. Nemaura Medical Inc.
  • 31.11. Bionime GmbH
  • 31.12. Acon Laboratories Inc.
  • 31.13. Nipro India Corporation Private Limited
  • 31.14. Rossmax International Ltd
  • 31.15. AgaMatrix Inc.

32. Global Blood Glucose Monitoring Systems Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Blood Glucose Monitoring Systems Market

34. Recent Developments In The Blood Glucose Monitoring Systems Market

35. Blood Glucose Monitoring Systems Market High Potential Countries, Segments and Strategies

  • 35.1 Blood Glucose Monitoring Systems Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Blood Glucose Monitoring Systems Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Blood Glucose Monitoring Systems Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer